| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 3e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |